Bnp Paribas »

Vertex Pharmaceuticals Incorporated shares owned by Bnp Paribas

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Bnp Paribas from 13F filings

Historical chart of Bnp Paribas investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Bnp Paribas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Bnp Paribas

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6M 5.7k 465.08
2024-06-30 $2.8M 5.9k 468.72
2024-03-31 $3.0M 7.1k 418.01

More positions owned by Bnp Paribas

iShares iBoxx High Yield Corporate Bond ETF Fund (HYG)
iShares iBoxx Investment Grade Corporate Bond ETF Fund (LQD)
Microsoft Corp Equity (MSFT)
Nvidia Corporation Equity (NVDA)
Apple Equity (AAPL)
Amazon Equity (AMZN)
Broadcom Equity (AVGO)
Alphabet Inc Cap Stk Cl C Equity (GOOG)
Palo Alto Networks Equity (PANW)
Jpmorgan Chase & Co Equity (JPM)
Visa Inc Com Cl A Equity (V)
Invesco Senior Loan ETF Fund (BKLN)
Applied Matls Equity (AMAT)
Parker-hannifin Corp Equity (PH)
Coca Cola Equity (KO)

View all positions for Bnp Paribas

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated